Kalaris Therapeutics, Inc. Common Stock (KLRS)

Typically moves ±4.12% on earnings

EARNINGS ANALYTICS

event_upcoming Next Earnings: 2026-11-06 HIGH CONFIDENCE

Kalaris Therapeutics, Inc. Common Stock (KLRS) has reported earnings 16 times since Aug 06, 2021. The stock moves an average of ±4.12% the day after reporting, closing higher 43.8% of the time. Its largest post-earnings gain was +14.38% (Nov 02, 2023) and its largest decline was -9.56% (Aug 13, 2025). The next earnings report is predicted for 2026-11-06 (high confidence).

Earnings reactions

How KLRS moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±4.12%

Positive %

43.8%

Negative %

56.2%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 11, 2026	☀ PRE	+1.27%	open_in_new
May 12, 2026	☀ PRE	+1.05%	open_in_new
Mar 17, 2026	☀ PRE	-3.13%	open_in_new
Nov 12, 2025	☀ PRE	-0.79%	open_in_new
Aug 13, 2025	☀ PRE	-9.56%	open_in_new
May 14, 2025	☀ PRE	+1.83%	open_in_new
Nov 02, 2023	☀ PRE	+14.38%	open_in_new
Aug 03, 2023	☀ PRE	-1.65%	open_in_new
May 04, 2023	☀ PRE	+10.39%	open_in_new
Feb 15, 2023	☀ PRE	-4.87%	open_in_new
Nov 03, 2022	☀ PRE	-1.42%	open_in_new
Aug 04, 2022	☀ PRE	+12.41%	open_in_new
May 05, 2022	☀ PRE	-0.71%	open_in_new
Feb 10, 2022	☀ PRE	-0.59%	open_in_new
Nov 05, 2021	☀ PRE	-0.53%	open_in_new
Aug 06, 2021	☀ PRE	+1.29%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±4.12%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 10 →

Funds holding

$2258122

Total value held

Flat

4 added · 4 reduced

Ubs Group Ag

$1066873 NEW BUY

Raymond James Financial Inc

$395457 -18.27%

Morgan Stanley

$294367 +88.62%

Blackrock, Inc.

$221580 +51.05%

State Street Corp

$107896 Held

SEC Filing Types

description SCHEDULE 13D/A

1 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260828	open_in_new SEC.gov
10-Q	20260811	open_in_new SEC.gov
8-K	20260811	open_in_new SEC.gov
3	20260803	open_in_new SEC.gov
4	20260803	open_in_new SEC.gov
3	20260727	open_in_new SEC.gov
3	20260720	open_in_new SEC.gov
4	20260720	open_in_new SEC.gov
8-K	20260720	open_in_new SEC.gov
8-K	20260717	open_in_new SEC.gov

Frequently asked about KLRS earnings

When does Kalaris Therapeutics, Inc. Common Stock report earnings next? expand_more

Kalaris Therapeutics, Inc. Common Stock (KLRS)'s next earnings date is predicted (high confidence) for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does KLRS stock move after earnings? expand_more

Over 16 reports, KLRS has moved an average of ±4.12% the session after earnings, closing higher 43.8% of the time.

What was KLRS's biggest post-earnings move? expand_more

KLRS's largest post-earnings gain on record was +14.38% on Nov 02, 2023, and its largest decline was -9.56% on Aug 13, 2025.

Where can I find Kalaris Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of Kalaris Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.